Methods for genetic risk prediction have been widely investigated in recent years. However, most available training data involves European samples, and it is currently unclear how to accurately predict disease risk in other populations. Previous studies have used either training data from European samples in large sample size or training data from the target population in small sample size, but not both. Here, we introduce a multiethnic polygenic risk score approach, MultiPRS, that combines training data from European samples and training data from the target population. We applied MultiPRS to predict type 2 diabetes in a Latino cohort using both publicly available European summary statistics in large sample size and Latino training data in small sample size, and observed a >70% relative improvement in prediction accuracy compared to methods that use only one source of training data, consistent with large relative improvements observed in simulations. Notably, this improvement is contingent on the use of ancestryadjusted coefficients in MultiPRS. Our work reduces the gap in risk prediction accuracy between European and non-European target populations.
Introduction
Genetic risk prediction is an important and widely investigated topic because of its potential clinical application as well as its application to better understand the underlying genetic architecture of complex traits. Many polygenic risk prediction methods have been developed and applied to complex traits. These include polygenic risk scores (PRS) [1] [2] [3] [4] [5] [6] [7] , which use summary association statistics as training data, and Best Linear Unbiased Predictor (BLUP) methods and their extensions [8] [9] [10] [11] [12] [13] [14] , which require raw genotype/phenotype data . However, all of these methods are inadequate for polygenic risk prediction in nonEuropean populations, because they consider training data from only a single population. Indeed, ref. 7 reported a relative decrease of 53-89% in schizophrenia risk prediction accuracy in Japanese and African American populations compared to Europeans when applying PRS methods using European training data; this decrease is an expected consequence of different patterns of linkage disequilibrium (LD) in different populations 15 . An alternative is to use training data from the same population as the target population, but this would generally imply a lower sample size, reducing prediction accuracy.
To tackle this problem, we developed a method, MultiPRS, that combines PRS based on European training data with PRS based on training data from the target population. The method takes advantage of both the accuracy that can be achieved with large training samples 3,4 and the accuracy that can be achieved with training data containing the same LD patterns as the target population.
In simulations and application to predict type 2 diabetes (T2D) in Latino target samples in the SIGMA T2D data set 16 , MultiPRS attains a >70% relative improvement in prediction accuracy compared to methods that use only one source of training data. This improvement is contingent on the use of ancestry-adjusted coefficients, as methods that use coefficients that are not adjusted for ancestry perform much worse than MultiPRS.
Methods

Overview of Methods
We explored 5 different prediction methods in our simulations and application to T2D: European training data only (EUR); Latino training data only (LAT); Latino training data and an ancestry predictor based on the proportion of European ancestry (LAT+ANC); optimal linear combination of predictions from European training data and Latino training data (EUR+LAT); and optimal linear combination of predictions from European training data, Latino training data and an ancestry predictor (MultiPRS). For each of the methods using Latino training data we used 10-fold cross-validation within the SIGMA T2D Latino data set. Latino effect sizes were adjusted for genome-wide ancestry in all primary analyses 17 , but we also considered methods with unadjusted Latino effect sizes as a secondary analysis. For each method, we built predictions by LD-pruning the SNPs and then thresholding on SNPs with P-value below a threshold, a widely used approach [1] [2] [3] [4] . We used squared correlation (R 2 on the observed scale) between predicted phenotype and phenotype as our primary measure of prediction accuracy.
Genetic Model
Let Y be the 1 x N phenotype vector with elements Y j , and let X be the M x N genotype matrix with elements g ij , where j = 1,...,N is the number of samples and i = 1,...,M is the number of genetic markers. We assume that the phenotype Y has E(Y)=0 and var(Y)=1, and that genotypes g ij are mean-centered with missing data to 0. We assume that the phenotype is a linear combination of genetic and environmental effects:
Polygenic risk score and LD-pruning + P-value thresholding.
We define the polygenic risk score 1 
∑ , where the marginal least square
We use LD-pruning and P-value thresholding as follows. We first LD-prune the SNPs based on a pairwise threshold R LD 2 , and then restrict to SNPs with an association P-value below a fixed threshold P T . We investigated different values of the pruning threshold R LD 2 , and ultimately fixed R LD 2 at 0.8 since this value consistently performed best. We perform a grid search over different values of the P-value threshold P T : 1.0, 0.8, 0.5, 0.4, 0.3, 0.2, 0.1, 0.08, 0.05, 0.02, 0.01, 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , 10 -8 . We optimize P T via an in-sample fit on validation samples, consistent with previous work [1] [2] [3] [4] . We performed LDpruning and P-value thresholding using PLINK2 (see Web Resources).
Prediction methods
We considered 5 different methods for prediction in Latino target samples: EUR, LAT, LAT+ANC, EUR+LAT and MultiPRS. EUR builds predictions using estimated effect sizes from European training data, using LD-pruning and P-value thresholding as described above:
LAT builds predictions using estimated effect sizes from Latino training data, using LDpruning and P-value thresholding:
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LAT+ANC builds predictions using the best linear combination of LAT and ancestry along the top 2 PCs (ANC): PRS LAT +ANC , j =α 1 PRS j +α 2 PC j , where PC j is a 2 x 1 vector containing the top 2 PCs. We optimize this linear combination via an in-sample fit on validation samples.
EUR+LAT builds predictions using the best linear combination of EUR and LAT:
PRS EUR+LAT , j =α 1 PRS EUR, j +α 2 PRS LAT , j . We optimize this linear combination via an insample fit on validation samples. We optimize different P-value thresholds for EUR and LAT, performing a 2-dimensional grid search.
MultiPRS builds predictions using the best linear combination of EUR, LAT, and ancestry along the top 2 PCs (ANC): PRS MultiPRS , j =α 1 PRS EUR, j +α 2 PRS LAT , j +α 3 PC j . We optimize this linear combination via an in-sample fit on validation samples. We optimize different P-value thresholds for EUR and LAT, performing a 2-dimensional grid search.
Simulations
We simulated quantitative phenotypes using real genotypes from European (WTCCC2) and Latino (SIGMA) data sets (see below). We fixed the proportion of causal markers at 1% and fixed SNP-heritability h g 2 at 0.5, and sampled normalized effect sizes β i from a normal distribution with variance equal to h g 2 divided by the number of causal markers.
We calculated per-allele effect sizes b i as , where p i is the minor allele frequency of SNP i in the European data set. We simulated phenotypes as , where . In our primary simulations, we discarded the causal SNPs and used only the non-causal SNPs as input to the prediction methods (i.e. we simulated untyped causal SNPs, which we believe to be most realistic). We also considered simulations in which we included the causal SNPs as input to the prediction methods (typed causal SNPs) as a secondary analysis.
We also performed simulations in which Latino phenotypes were explicitly correlated to ancestry. In these simulations, we added a constant multiple of PC1 (representing European vs. Native American ancestry, with positive values representing higher European ancestry) to the Latino phenotypes such that the correlation between phenotype and PC1 was equal to -0.11, which is the correlation between T2D phenotype and PC1 in the SIGMA data set.
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To assess the gap in risk prediction accuracy between European and Latino target populations, we also computed polygenic risk scores in Europeans via 10-fold crossvalidation in the European data set, using LD-pruning and P-value thresholding.
WTCCC2, SIGMA and DIAGRAM data sets.
Our simulations used real genotypes from the WTCCC2 and SIGMA data sets. The WTCCC2 data set consists of 15,622 unrelated European samples genotyped at 360,557 SNPs after QC 18, 19 . The SIGMA data set consists of 8,214 unrelated Latino samples genotyped at 2,440,134 SNPs after QC 16 . We restricted our simulations to 232,629 SNPs present in both data sets (with matched reference and variant alleles) after removing A/T and C/G SNPs due to strand ambiguity.
Our analyses of type 2 diabetes used summary association statistics from DIAGRAM data set and genotypes and phenotypes from the SIGMA data set. The DIAGRAM data set consists of 12,171 cases and 56,862 controls of European ancestry for which summary association statistics at 2,473,441 imputed SNPs are publicly available (see Web Resources) 20 . As noted above, the SIGMA data set consists of 8,214 unrelated Latino samples (3,848 type 2 diabetes cases and 4,366 controls) genotyped at 2,440,134 SNPs after QC. We restricted our analyses of type 2 diabetes to 776,374 SNPs present in both data sets (with matched reference and variant alleles) after removing A/T and C/G SNPs due to strand ambiguity. For the SIGMA data set, we used the top 2 PCs as computed in ref. 16 . We also performed an analysis of type 2 diabetes using imputed genotypes from the SIGMA T2D data set 16 , restricting to 2,062,617 present in both data sets (with matched reference and variant alleles) after removing A/T and C/G SNPs due to strand ambiguity.
Results
Simulations.
We performed simulations using real genotypes and simulated phenotypes. We simulated continuous phenotypes under a non-infinitesimal model with 1% of markers chosen to be causal and SNP-heritability h g 2 = 0.5 (see Methods); we report the average R 2 and standard deviation over 100 simulations. We used WTCCC2 18, 19 data (15,622 samples after QC, see Methods) as the European training data, and the SIGMA data 16 (8,214 samples) as the Latino training and validation data (with 10-fold cross-validation). We simulated phenotypes using the 232,629 SNPs present in both data sets and built predictions from these SNPs excluding the causal SNPs, modeling the causal SNPs as untyped (see Methods).
Prediction accuracies (R 2 ) and optimal weights for the 5 main methods (EUR, LAT, LAT+ANC, EUR+LAT, MultiPRS) are reported in Table 1 (optimal P-value thresholds for each method are reported in Supplementary Table 1 ). The EUR and LAT methods, which each use only one source of training data, performed similarly. This reflects a tradeoff between the larger training sample size for EUR and the target-matched LD patterns for LAT (confirmed by higher accuracy when using EUR training data to predict in Europeans; Table 1 caption). EUR+LAT attained a >78% relative improvement over either EUR or LAT (and chose similar weights for EUR and LAT), highlighting the advantages of incorporating multiple sources of training data. When including an ancestry predictor, we observed a relative improvement of 20% for MultiPRS compared to EUR+LAT, reflecting small genetic effects of ancestry on phenotype that can arise from random genetic drift between populations at causal markers.
Predictions using Latino effect sizes that were not adjusted for genetic ancestry (LAT unadj , EUR+LAT unadj , EUR+LAT unadj +ANC, as compared to LAT, EUR+LAT, MultiPRS) were much less accurate (Supplementary Table 1 ), consistent with previous work 17 ; this is a consequence of the fact that LAT unadj predictions were dominated by genetic ancestry (R 2 = 0.86; Supplementary Table 2) . We also observed a modest correlation (R 2 = 0.15) between the EUR prediction and genetic ancestry (Supplementary Table 2 ), again reflecting small genetic effects of ancestry on phenotype that can arise from random genetic drift between populations at causal markers. The relative performance of the different prediction methods was similar in simulations in which phenotypes explicitly contained an ancestry term, representing environmentally driven stratification (Supplementary Table 3 ).
We extrapolated the results in Table 1 to larger sample sizes by limiting the simulations to subsets of chromosomes, as in previous work 7 ( Figure 1 and Supplementary Table 4) . MultiPRS was the best performing method in each of these experiments. We also performed simulations using predictions from all SNPs including the causal SNPs (Supplementary Figure 1 and Supplementary Table 5 ). In these experiments, MultiPRS was once again the best performing method, but now EUR performed much better than LAT, consistent with the larger training sample size for EUR and the fact that differential tagging of causal SNPs is of reduced importance when causal SNPs are typed.
Analyses of type 2 diabetes.
We applied the same methods to predict T2D in Latino target samples from the SIGMA T2D data set. We used publicly available European summary statistics from DIAGRAM 20 as European training data (12,171 cases and 56,862 controls; effective sample size = 40,100) and SIGMA T2D genotypes and phenotypes 16 (3,848 cases and 4,366 controls; effective sample size = 8,181) as Latino training and validation data, employing 10-fold cross-validation.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/051458 doi: bioRxiv preprint first posted online May. 2, 2016; Prediction accuracies (R 2 ) and optimal weights for the 5 main methods (EUR, LAT, LAT+ANC, EUR+LAT, MultiPRS) are reported in Table 2 (other prediction metrics are  reported in Supplementary Table 6 ). EUR performed only 44% better than LAT despite the much larger training sample size, again reflecting a tradeoff between sample size and target-matched LD patterns. EUR+LAT attained improvements ranging from 72%-148% over EUR and LAT respectively (and chose slightly higher weights for EUR than for LAT), again highlighting the advantages of incorporating multiple sources of training data. Although adding an ancestry predictor to LAT produced a substantial improvement (LAT+ANC vs. LAT), adding an ancestry predictor to EUR+LAT produced only a very small improvement for MultiPRS compared to EUR+LAT; this can be explained by the large negative correlation between the European PRS (EUR) and European ancestry (R = -0.70; Supplementary Table 7 ), such that any predictor that includes EUR already includes effects of genetic ancestry. This correlation is far larger than analogous correlations due to random genetic drift in our simulations (Supplementary Table 2 ), suggesting that this systematically lower load of T2D risk alleles in Latino individuals with more European ancestry could be due to polygenic selection 21, 22 in ancestral European and/or Native American populations; previous studies using top GWASassociated SNPs have also reported continental differences in genetic risk for T2D 23, 24 . As in our simulations, predictions using Latino effect sizes that were not adjusted for genetic ancestry (LAT unadj , EUR+LAT unadj , EUR+LAT unadj +ANC, as compared to LAT, EUR+LAT, MultiPRS) were much less accurate (Supplementary Table 8 ), a consequence of the fact that these predictions were dominated by genetic ancestry (Supplementary Table 9 ). We also computed predictions for each method using imputed SNPs from the SIGMA T2D data set; this did not improve prediction accuracy, but MultiPRS was still the best performing method (Supplementary Table 10 ).
We investigated how the prediction accuracy of each method varied as a function of Pvalue thresholds, by varying either the EUR P-value threshold (Figure 2a and  Supplementary Table 11 ) or the LAT P-value threshold (Figure 2b and Supplementary  Table 12 ). In both cases, permissive P-value thresholds performed best, reflecting the relatively small sample sizes analyzed. However, the prediction accuracy of MultiPRS was relatively stable, with prediction R 2 > 3.7% across all EUR P-value thresholds ( Figure 2a) and R 2 > 3.4% across all LAT p-value thresholds (Figure 2b) . In Figure 2a , we observe that as the EUR P-value threshold becomes more stringent, the difference in prediction accuracy between MultiPRS and EUR+LAT increases, because EUR is less able to capture polygenic ancestry effects (see above).
Discussion
We have shown that MultiPRS attains a >70% improvement in prediction accuracy for type 2 diabetes in a Latino cohort compared to prediction methods that use training data from a single population. This improvement is consistent with simulations, and reduces the well-documented gap in risk prediction accuracy between European and nonEuropean target populations 7 . Intuitively, MultiPRS leverages both large training sample sizes and training data with target-matched LD patterns. We note that the effects of differential tagging (or different causal effect sizes) in different populations can
potentially be quantified using cross-population genetic correlation 25 , and that leveraging data from a different population to improve predictions is a natural analogue to leveraging data from a correlated trait 12 .
Despite the advantages of MultiPRS, our work is subject to several limitations. First, although we have demonstrated large relative improvements in prediction accuracy, absolute prediction accuracies are currently not large enough to be clinically useful, which will require larger sample sizes 3 . Second, it may be possible to attain higher prediction accuracy using methods that fit all markers simultaneously, such as Best Linear Unbiased Predictor (BLUP) methods and their extensions [8] [9] [10] [11] [12] [13] [14] . However, these methods require raw genotypes/phenotype data, which is not available for the European type 2 diabetes summary statistics that we analyzed here. Third, our LDpred risk prediction method 7 , which analyzes summary statistics in conjunction with LD information from a reference panel, is more accurate in European populations than the LD-pruning + p-value thresholding approach employed by MultiPRS. However, we elected not to employ LDpred in the current setting due to the complexities of admixture-LD when using LD information from a reference panel in admixed populations 26 . Fourth, our work has highlighted the importance of validating predictions using a separate cohort (instead of cross-validation within the same cohort) in order to avoid inflation in prediction accuracies due to population stratification effect 7 . However, we believe this issue is not substantially affecting our conclusions, both because our empirical results are consistent with simulations and because the type 2 diabetes prediction accuracy we obtained in a Latino-only (LAT) prediction scheme with no P-value thresholding (R 2 = 0.017; see Supplementary Table 13 ) imply values of SNP-heritability (h g,obs 2 = 0.39; h g,liab 2 = 0.38 assuming 8% prevalence 2 ) that are consistent with previous estimates 2 . Fifth, MultiPRS includes an ancestry predictor, but in some cases it may be preferable to construct and evaluate a predictor that does not benefit from ancestry information; we note that very similar results for type 2 diabetes were obtained using a prediction method (EUR+LAT) that does not include the ancestry predictor. Sixth, we optimize P-value thresholds and weights for each predictor via an in-sample fit on validation samples, consistent with widely used LD-pruning and P-value thresholding methods [1] [2] [3] [4] ; an additional layer of validation using samples not used to fit those parameters would formally be most statistically appropriate, but is unlikely to impact our results given the small number of parameters (up to two P-value thresholds and weights for EUR, LAT, and two ANC predictors) and fairly large validation sample (N=8,214), as we have demonstrated in previous work 17 . Seventh, we have not considered here how to improve prediction accuracy in data sets with related individuals 13 . Eighth, we focused our analyses on common variants, but future work may wish to consider rare variants as well. Finally, we have only considered a Latino target population, but it is also of interest to apply MultiPRS to other non-European target populations. Table 1 . Accuracy of 5 prediction methods in simulations. We report average R 2 on the observed scale over 100 simulations for each of the 5 main prediction methods. We assessed prediction accuracy in European target sample using 10-fold cross-validation and obtained R 2 =0.031 (s.e.=0.0006).
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Figure 2. Accuracy of 5 prediction methods in analyses of type 2 diabetes as a function of P-value thresholds. We report prediction accuracies for each of the 5 main prediction methods as a function of (a) EUR P-value threshold, where applicable (with optimized LAT P-value threshold, where applicable) and (b) LAT P-value threshold, where applicable (with optimized EUR P-value threshold, where applicable). Numerical results are provided in Supplementary Table 11 and Supplementary Table 12. peer Accuracy of 9 prediction methods in simulations. We report prediction accuracies for methods using both ancestry-adjusted Latino effect sizes (LAT) and ancestry-unadjusted Latino effect sizes (LAT unadj ). Reported values are mean R 2 on the observed scale over 100 simulations.
peer Supplementary Table 3 . Accuracy of 9 prediction methods in simulations with ancestry-correlated phenotypes. We report prediction accuracies for methods using both ancestry-adjusted Latino effect sizes (LAT) and ancestry-unadjusted Latino effect sizes (LAT unadj ). Reported values are mean R 2 on the observed scale over 100 simulations . Table 4 . Numerical values of results displayed in Figure 1 . We report prediction accuracies for each of the 5 main prediction methods, for each subset of chromosomes.
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Supplementary Figures
Supplementary Figure 1 . Accuracy of 5 prediction methods in simulations using subsets of chromosomes, including the causal SNPs. We report prediction accuracies for each of the 5 main prediction methods as a function of Msim/M, where M=232,629 is the total number of SNPs and Msim is the actual number of SNPS used in each simulation: 232,629 (all chromosomes), 68,188 (chromosomes 1-4), 38412 (chromosomes 1-2), and 19087 (chromosome 1). Numerical results are provided in Supplementary Table 5. peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
